Probiotic properties, whole-genome sequence analysis, and safety assessment of BreviBacillus borstelensis S8

Abstract

In previous studies, BreviBacillus borstelensis S8 exhibited favorable enzyme production characteristics. In this study, the whole genome of Br borstelenensis S8 was sequenced to analyze its genomic sequence information and functions, investigating its genotype and potential probiotic properties. The whole genome sequence of S8 was determined to be 5,559,180 bp with an average GC content of 51.5%. A total of 5406 protein-coding genes were identified and annotated using NCBI Prokaryotic Genome Annotation. By comparing it with the complete genome sequences of Bacillus cereus strains, 1911 orthologous gene families were recognized. Genome analysis revealed the absence of active antibiotic resistance genes, virulence factor genes, and toxin-encoding genes. Safety assessments included hemolytic assays, antibiotic resistance tests, and evaluations of biogenic amine production. Functional gene analysis highlighted S8's metabolic pathways based on its genomic features. The presence of adhesion-related genes, stress response genes (e.g., acid and bile salts), antimicrobial gene clusters, and genes involved in vitamin and essential amino acid synthesis in the genome showcased the probiotic potential of S8. Simultaneously, analysis of hemolytic activity, biogenic amines production ability, acid and bile salt tolerance for the strain S8 also demonstrated its probiotic traits. The genomic exploration and probiotic activity of S8 revealed its potential as a probiotic, offering valuable genomic insights and a foundation for its safe utilization in the food industry.